arthroplasty was approximately 8.2%1 . In economic terms, revision total hip arthroplasty is estimated to have consumed 19% of the Medicare hip replacement expenditures between 1997 to 2003, whereas total knee arthroplasty revisions consumed only 8% of the total annual Medicare expenditures for knee replacement2 . In Scandinavia, England, Australia, and Canada, the numbers of these procedures that have been performed are readily obtainable from national arthroplasty registries3-6. However, in the United States, the American Academy of Orthopaedic Surgeons (AAOS)7 and other investigators have had to rely on representative surveys of hospital discharge records to provide estimates of the prevalence of primary and revision arthroplasties1,8. Given the many years required for the training of surgeons and the equally complex task of planning for hospital capacity, reliable projections regarding the demand for arthroplasties are crucial for policy makers in government, education, and industry. Importantly, reliable projections of revision arthroplasties would be particularly useful, as they consume greater economic resources than do primary procedures9 . O Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are affiliated or associated. J Bone Joint Surg Am. 2007;89:780-5 • doi:10.2106/JBJS.F.00222 781 THE JOURNAL OF BONE & JOINT SURGERY · JBJS.ORG VOLUME 89-A · NUMBER 4 · APRIL 2007 PROJECTIONS OF PRIMARY AND REVISION HI P AND KNEE ARTHROPLASTY I N THE UNITED STATES FROM 2005 TO 2030 For this study, we hypothesized that the demand for total hip and total knee arthroplasties in the United States will increase substantially over the next twenty-five years. To test this hypothesis, we performed statistical projections of the number of primary and revision total hip and total knee arthroplasties between 2005 and 2030 on the basis of the available historical Nationwide Inpatient Sample (NIS) data from 1990 to 200310, compared with projections assuming a constant prevalence. Materials and Methods Data Sources he National Hospital Discharge Survey (NHDS) and the NIS are national (United States) sample surveys of hospital discharge records. Comparisons of the two surveys conducted by the Agency for Healthcare Research and Quality have found that, on a year-by-year basis, the numbers of surgical procedures estimated to have been performed from the NIS and the NHDS are similar, differing by approximately 10%11. However, the NIS collects a substantially larger number of discharge records than does the NHDS and is therefore better suited to accurately quantify the prevalence of inpatient arthroplasty procedures in the United States. Consequently, we relied on the NIS data from 1990 to 2003 for our projections for the current study. The NIS is a federal-state cooperative database designed to compile annually a representative sample of hospital discharge records in the United States. In 2003, the NIS had a sample size of about eight million discharge records from approximately 1000 hospitals, which represent approximately 20% of all United States community hospitals. All of the discharge records from 1990 to 2003 were examined for this study. We obtained demographic data on the patients (e.g., age, gender, and race and/or ethnicity) from the NIS. Disease diagnoses and surgical procedures performed (if any) were recorded for the NIS with use of the Ninth Revision of the International Classification of Diseases (ICD-9-CM). Specifically, primary hip and knee arthroplasty are identified by the ICD-9-CM codes 81.51 and 81.54, respectively. For revisions, the corresponding codes are 81.53 and 81.55. From 1990 to 2003, the ICD-9-CM codes for these procedures were consistent, thereby allowing the determination of longitudinal trends in the prevalence of both primary and revision joint arthroplasty. We also used projected population statistics for the nation and for individual states by age, gender, and race and/or ethnicity through 2025 that were published by the Census Bureau in 199712. Projection Methodology and Statistical Analyses The annual prevalence of arthroplasty surgery was modeled with use of a Poisson regression with age, gender, race and/or ethnicity, census region, and calendar year as covariates to account for differences in prevalence among population subgroups as well as changes over time. Age was categorized into eight subgroups (less than forty-five, forty-five to fifty-four, fifty-five to sixty-four, sixty-five to sixty-nine, seventy to seventyfour, seventy-five to seventy-nine, eighty to eighty-four, and eighty-five or more years old), while race and/or ethnicity was grouped into five categories (white, black, Asian, Hispanic, and Native American). “Hispanic” included all patients of Hispanic origin, regardless of race. Four census regions (Northeast, South, Midwest,